Overview

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
Phase:
Phase 3
Details
Lead Sponsor:
Kythera Biopharmaceuticals
Collaborator:
Bayer
Treatments:
Deoxycholic Acid